Literature DB >> 24662057

Correlation of genetic risk and messenger RNA expression in a Th17/IL23 pathway analysis in inflammatory bowel disease.

Karin Fransen1, Suzanne van Sommeren, Harm-Jan Westra, Monique Veenstra, Letitia E Lamberts, Rutger Modderman, Gerard Dijkstra, Jingyuan Fu, Cisca Wijmenga, Lude Franke, Rinse K Weersma, Cleo C van Diemen.   

Abstract

BACKGROUND: The Th17/IL23 pathway has both genetically and biologically been implicated in the pathogenesis of the inflammatory bowel diseases (IBD), Crohn's disease, and ulcerative colitis. So far, it is unknown whether and how associated risk variants affect expression of the genes encoding for Th17/IL23 pathway proteins.
METHODS: Ten IBD-associated SNPs residing near Th17/IL23 genes were used to construct a genetic risk model in 753 Dutch IBD cases and 1045 controls. In an independent cohort of 40 Crohn's disease, 40 ulcerative colitis, and 40 controls, the genetic risk load and presence of IBD were correlated to quantitative PCR-generated messenger RNA (mRNA) expression of 9 representative Th17/IL23 genes in both unstimulated and PMA/CaLo stimulated peripheral blood mononuclear cells. In 1240 individuals with various immunological diseases with whole genome genotype and mRNA-expression data, we also assessed correlation between genetic risk load and differential mRNA expression and sought for SNPs affecting expression of all currently known Th17/IL23 pathway genes (cis-expression quantitative trait locus).
RESULTS: The presence of IBD, but not the genetic risk load, was correlated to differential mRNA expression for IL6 in unstimulated peripheral blood mononuclear cells and to IL23A and RORC in response to stimulation. The cis-expression quantitative trait locus analysis showed little evidence for correlation between genetic risk load and mRNA expression of Th17/IL23 genes, because we identified for only 2 of 22 Th17/IL23 genes a cis-expression quantitative trait locus single nucleotide polymorphism that is also associated to IBD (STAT3 and CCR6).
CONCLUSIONS: Our results suggest that only the presence of IBD and not the genetic risk load alters mRNA expression levels of IBD-associated Th17/IL23 genes.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24662057     DOI: 10.1097/MIB.0000000000000013

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  9 in total

1.  Increased IL-17A/IL-17F expression ratio represents the key mucosal T helper/regulatory cell-related gene signature paralleling disease activity in ulcerative colitis.

Authors:  Yoichiro Iboshi; Kazuhiko Nakamura; Keita Fukaura; Tsutomu Iwasa; Haruei Ogino; Yorinobu Sumida; Eikichi Ihara; Hirotada Akiho; Naohiko Harada; Makoto Nakamuta
Journal:  J Gastroenterol       Date:  2016-05-13       Impact factor: 7.527

2.  IL12B and IL23R polymorphisms are associated with alopecia areata.

Authors:  Pardis-Sadat Tabatabaei-Panah; Hamideh Moravvej; Sara Delpasand; Mona Jafari; Sanaz Sepehri; Reyhaneh Abgoon; Ralf J Ludwig; Reza Akbarzadeh
Journal:  Genes Immun       Date:  2020-05-01       Impact factor: 2.676

3.  Proinflammatory effects and molecular mechanisms of interleukin-17 in intestinal epithelial cell line HT-29.

Authors:  Yi-Lin Wang; Meng Fang; Xiao-Ming Wang; Wei-Yan Liu; Yun-Jiang Zheng; Xu-Bo Wu; Ran Tao
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

4.  IL-23/Th17 pathway and IL-17A gene polymorphism in Egyptian children with immune thrombocbytopenic purpura.

Authors:  Ahlam M Ismail; Aliaa M Higazi; Hanan M Nomeir; Naglaa M Farag
Journal:  Ital J Pediatr       Date:  2021-08-26       Impact factor: 2.638

5.  The role of IL-23/Th17 pathway in patients with primary immune thrombocytopenia.

Authors:  Xin Ye; Lei Zhang; Hui Wang; Yan Chen; Weiwei Zhang; Rongrong Zhu; Chaoping Fang; Anmei Deng; Baohua Qian
Journal:  PLoS One       Date:  2015-01-26       Impact factor: 3.240

Review 6.  Th17 cells in autoimmune and infectious diseases.

Authors:  José Francisco Zambrano-Zaragoza; Enrique Jhonatan Romo-Martínez; Ma de Jesús Durán-Avelar; Noemí García-Magallanes; Norberto Vibanco-Pérez
Journal:  Int J Inflam       Date:  2014-08-03

Review 7.  The Centenary of Immune Thrombocytopenia - Part 1: Revising Nomenclature and Pathogenesis.

Authors:  Rita Consolini; Annalisa Legitimo; Maria Costanza Caparello
Journal:  Front Pediatr       Date:  2016-10-19       Impact factor: 3.418

8.  Interleukin-23 may contribute to the pathogenesis of lumbar disc herniation through the IL-23/IL-17 pathway.

Authors:  Hongqiang Jiang; Yao Deng; Tao Wang; Jianxiong Ma; Pengfei Li; Peng Tian; Chao Han; Xinlong Ma
Journal:  J Orthop Surg Res       Date:  2016-01-16       Impact factor: 2.359

9.  Selective IL-23 Inhibition by Risankizumab Modulates the Molecular Profile in the Colon and Ileum of Patients With Active Crohn's Disease: Results From a Randomised Phase II Biopsy Sub-study.

Authors:  Sudha Visvanathan; Patrick Baum; Azucena Salas; Richard Vinisko; Ramona Schmid; Kristie M Grebe; Justin W Davis; Kori Wallace; Wulf O Böcher; Steven J Padula; Jay S Fine; Julián Panés
Journal:  J Crohns Colitis       Date:  2018-11-09       Impact factor: 9.071

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.